Form 8-K - Current report:
SEC Accession No. 0001193125-17-339920
Filing Date
2017-11-13
Accepted
2017-11-13 08:18:56
Documents
5
Period of Report
2017-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d475110d8k.htm 8-K 16001
2 EX-99.1 d475110dex991.htm EX-99.1 16299
3 GRAPHIC g475110g1110233502732.jpg GRAPHIC 4693
4 GRAPHIC g475110g1110233502826.jpg GRAPHIC 5617
5 GRAPHIC g475110g1110233502919.jpg GRAPHIC 8227
  Complete submission text file 0001193125-17-339920.txt   59572
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 171193273
SIC: 2834 Pharmaceutical Preparations